Seraphima Ventures LLC is focusing on mainly nanotechnology startup companies with existing products, not blue sky research. The current venture capital business models are not appropriate for investing in Nanotechnology. We are proposing a new business model which combines the best of both worlds of venture capital and angel investing which is a more hands-on approach to managing companies to success. Seraphima is a play on the word "seraphim", an angel, for the investment approach of this fund. This does not mean we are limited to funding with angel money.

Nanotechnologies have potential to add significant value in performance and eventually lower cost to many products across all sectors. These commercial benefits are happening much sooner than most people think.

President Bush in his January 2006 State of the Union address says he wishes to double funding in R&D including nanotechnology. By the end of 2005, governments spent US$18 Billion of taxpayer money into nanotech R&D. US$6 Billion are forecast for 2006. President Bush signed the Nanotech bill on Wednesday, December 3, 2003 for US$3.7 Billion over the next 4 years starting 2005 for nanotech research. This does not even include the nanotechnology funding set aside for military and defense related applications. The signing of the bill by President Bush makes nanotechnology the highest federally funded basic science and technology effort since the space race. The US only makes up about 25% of the global government spending on nanotech research with Japan just slightly ahead of the US. An NSF report states that Nanotech has the potential to grow to a US$1 Trillion per year industry.